Allegria Therapeutics secures USD 5.1 million in seed extension financing, led by ALK Abelló, to support its lead program aiming for pre-clinical candidates.
Amount Raised
$5.1 Million
Round Type
Seed
BaselBiotechnologyHealth CareInvestors
Description
Allegria Therapeutics, a Swiss biotech firm, has completed a USD 5.1 million seed extension financing. The round was led by ALK Abelló, with contributions from HighLight Capital, Lichtsteiner Foundation, and Forty51 Ventures. The funds will enhance the company's growth and advance its therapeutic programs targeting mast cell-mediated diseases. Allegria aims to bring innovative treatment options for patients with allergies and related inflammatory conditions.
Quick answer
Allegria Therapeutics raised $5.1 Million in a Seed round, dated December 11, 2025. Investors: Highlight Capital, Lichtsteiner Foundation, Forty51 Ventures and ALK Abelló. Allegria Therapeutics is based in Basel, Basel City, Switzerland.
- How much did Allegria Therapeutics raise?
- Allegria Therapeutics raised $5.1 Million in a Seed round on December 11, 2025.
- Who invested in Allegria Therapeutics?
- Highlight Capital, Lichtsteiner Foundation, Forty51 Ventures and ALK Abelló are named as investors in this round.
- What does Allegria Therapeutics do?
- Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023.
- Where is Allegria Therapeutics based and how big is it?
- Allegria Therapeutics is based in Basel, Basel City, Switzerland.
- Who are the decision-makers at Allegria Therapeutics?
- Fundz holds 1 contact at Allegria Therapeutics, including the Chief Executive Officer & Co-founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Allegria Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Axogen raised $124M (Post-IPO Equity) on January 23, 2026.
- Pi Health raised $8.6M on January 23, 2026.
- Cancilico raised $2.9M (Seed) on January 22, 2026.
- Mendra raised $82M (Series A) on January 22, 2026.
- Corxel Pharmaceuticals raised $287M (Series D) on January 22, 2026.
- Infinitopes raised $15M (Seed) on January 21, 2026.
Who to call at Allegria Therapeutics, and when
A new round usually means Allegria Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Allegria Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Allegria Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Allegria Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Allegria Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Allegria Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.